Vera Therapeutics Inc. (VERA)
36.06
0.00 (0.00%)
Upcoming Events
Latest Headlines
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026 4:05 PM - Globe NewsWire
Form 4 Vera Therapeutics, Inc. For: Jul 07 Filed by: Fordyce Marshall
July 9, 2026 4:45 PM - SEC Filing
Vera Therapeutics names Nancy Boman as chief regulatory officer
July 9, 2026 8:01 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jul 09
July 9, 2026 8:00 AM - SEC Filing
Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
July 9, 2026 8:00 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $78 at TD Cowen
July 8, 2026 8:09 AM - StreetInsider
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
July 8, 2026 7:47 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $76 at Guggenheim
July 8, 2026 6:50 AM - StreetInsider
Vera Therapeutics (VERA) PT Raised to $125 at H.C. Wainwright
July 8, 2026 6:42 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jul 07
July 7, 2026 12:46 PM - SEC Filing
FDA grants accelerated approval to Vera Therapeutics' kidney drug
July 7, 2026 12:39 PM - StreetInsider
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
July 7, 2026 12:37 PM - Globe NewsWire
Scilex, Vera Therapeutics rise premarket; Strategy gains
July 6, 2026 8:18 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: Jun 23 Filed by: Fordyce Marshall
June 24, 2026 4:56 PM - SEC Filing
Form 144 Vera Therapeutics, Inc. Filed by: Fordyce Marshall
June 23, 2026 4:30 PM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026 4:05 PM - StreetInsider
Jefferies Reiterates Buy Rating on Vera Therapeutics (VERA)
June 2, 2026 3:56 PM - StreetInsider
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
June 2, 2026 2:02 PM - StreetInsider
Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA'
June 2, 2026 12:28 PM - StreetInsider
Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'
June 2, 2026 11:15 AM - StreetInsider
Raymond James: ''If Vera is successful with this new plan, it could effectively shorten the theoretical lead Otsuka'
June 2, 2026 10:12 AM - StreetInsider
TD Cowen on Vera Therapeutics (VERA): 'Launch prep remains on track; we have confidence in a clean approval'
June 2, 2026 7:16 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Jun 02
June 2, 2026 7:05 AM - SEC Filing
Vera Therapeutics moves up atacicept analysis timeline with FDA agreement
June 2, 2026 7:00 AM - StreetInsider
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
June 2, 2026 7:00 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: May 21
May 26, 2026 4:55 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Morrison Scott W
May 26, 2026 4:40 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Cheng Andrew
May 26, 2026 4:40 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: SEIDENBERG BETH C
May 26, 2026 4:39 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Oliger Christy J.
May 26, 2026 4:38 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Meyers James R
May 26, 2026 4:34 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: Hall Kimball
May 26, 2026 4:32 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: MORRISSEY MICHAEL
May 26, 2026 4:30 PM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: May 21 Filed by: ENRIGHT PATRICK G
May 26, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
May 15, 2026 10:09 AM - SEC Filing
Vera Therapeutics (VERA) PT Lowered to $91 at Evercore ISI
May 15, 2026 7:15 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: May 12 Filed by: Fordyce Marshall
May 13, 2026 4:27 PM - SEC Filing
Form 144 Vera Therapeutics, Inc. Filed by: Fordyce Marshall
May 12, 2026 4:34 PM - SEC Filing
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026 4:05 PM - Globe NewsWire
Form 10-Q Vera Therapeutics, Inc. For: Mar 31
May 7, 2026 4:36 PM - SEC Filing
Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
May 7, 2026 7:32 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: May 07
May 7, 2026 7:30 AM - SEC Filing
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026 7:30 AM - Globe NewsWire
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
May 4, 2026 7:30 AM - Globe NewsWire
Full Article List
